• 349 Citations
  • 10 h-Index
20102019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Mi So Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 36 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Pemetrexed Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2019

  • 349 Citations
  • 10 h-Index
  • 36 Article

Pemetrexed in the Treatment of Leptomeningeal Metastasis in Patients With EGFR-mutant Lung Cancer

Choi, M., Keam, B., Ock, C. Y., Kim, M. S., Kim, T. M., Kim, D-W. & Heo, D. S., 1 Jul 2019, In : Clinical Lung Cancer. 20, 4, p. e442-e451

Research output: Contribution to journalArticleResearchpeer-review

Pemetrexed
Lung Neoplasms
Neoplasm Metastasis
Non-Small Cell Lung Carcinoma
Therapeutics
1 Citation (Scopus)
Chronic Kidney Failure
Dialysis
Safety
Renal Dialysis
Pneumonia

NK92-CD16 cells are cytotoxic to non-small cell lung cancer cell lines that have acquired resistance to tyrosine kinase inhibitors

PARK, HA. A. R. A. M., AHN, YONG. O. N. G. O. O. N., Kim, T. M., KIM, SOYEON., KIM, SEULKI., LEE, YU. SOO., Kim, M. S., Keam, B., KIM, DONG. O. N. G. W. A. N. & Heo, D. S., 1 Jun 2019, In : Cytotherapy. 21, 6, p. 603-611 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Cell Line
Immunotherapy
Monoclonal Antibodies
2 Citations (Scopus)
Tumor Microenvironment
Brain Neoplasms
Lung Neoplasms
Carcinogenesis
Neoplasm Metastasis

Inhibition of MEK with trametinib enhances the efficacy of anti-PD-L1 inhibitor by regulating anti-tumor immunity in head and neck squamous cell carcinoma

Kang, S. H., Keam, B., Ahn, Y. O., Park, H. R., Kim, M. S., Kim, T. M., Kim, D-W. & Heo, D. S., 2 Jan 2019, In : OncoImmunology. 8, 1, e1515057.

Research output: Contribution to journalArticleResearchpeer-review

Mitogen-Activated Protein Kinase Kinases
Immunity
Neoplasms
Major Histocompatibility Complex
T-Lymphocytes